Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts

Transplant International

Volumn 25, Issue 9, 2012, Pages 956-966

  Aini, Wulamujiang ^a   Miyagawa Hayashino, Aya ^a   Tsuruyama, Tatsuaki ^a,b   Hashimoto, Seiji ^a   Sumiyoshi, Shinji ^a   Ozeki, Munetaka ^b   Tamaki, Keiji ^b   Uemoto, Shinji ^a   Haga, Hironori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

abnormal karyotype; aneuploidy; FISH; pediatric transplantation; telomere

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ARTICLE; BILIARY TRACT DISEASE; CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPLICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INFANT; KARYOTYPING; LIVER BIOPSY; LIVER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MALE; POSTTRANSFUSION HEPATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TELOMERE SHORTENING; Y CHROMOSOME;

ADOLESCENT; ANEUPLOIDY; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS; HEPATOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; TELOMERE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84864705673     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01523.x     Document Type: Article

References (34)

1. Kelly DA,. Current issues in pediatric transplantation. Pediatr Transplant 2006; 10: 712.
2. Fouquet V, Alves A, Branchereau S, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005; 11: 152.
3. Evans HM, Kelly DA, McKiernan PJ, Hubscher S,. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109.
4. Ekong UD, Melin-Aldana H, Seshadri R, et al. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582.
5. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS,. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880.
6. Serrano MT, Garcia-Gil A, Arenas J, et al. Outcome of liver transplantation using donors older than 60 years of age. Clin Transplant 2010; 24: 543.
7. Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA,. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple models for end-stage liver disease-independent prognostic factors. Liver Transpl 2010; 16: 950.
8. McGlynn LM, Stevenson K, Lamb K, et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 2009; 8: 45.
9. Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 2008; 7: 491.
10. Eguchi S, Takatsuki M, Hidaka M, et al. Lack of grafted liver rejuvenation in adult-to-pediatric liver transplantation. Dig Dis Sci 2011; 56: 1542.
11. Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489.
12. Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T,. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int 2009; 22: 303.
13. Neil DA, Hubscher SG,. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23: 971.
14. Harley CB, Futcher AB, Greider CW,. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458.
15. Lechel A, Satyanarayana A, Ju Z, et al. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep 2005; 6: 275.
16. Aikata H, Takaishi H, Kawakami Y, et al. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 2000; 256: 578.
17. Wiemann SU, Satyanarayana A, Tsahuridu M, et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 2002; 16: 935.
18. Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y,. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology 2008; 48: 186.
19. Nakajima T, Moriguchi M, Katagishi T, et al. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. Liver Int 2006; 26: 23.
20. Sanada Y, Aida J, Kawano Y, et al. Hepatocellular Telomere Length in Biliary Atresia Measured by Q-FISH. World J Surg 2012; 36: 908.
21. Plentz RR, Park YN, Lechel A, et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007; 45: 968.
22. Sigal SH, Rajvanshi P, Gorla GR, et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 1999; 276: G1260.
23. Gupta S,. Hepatic polyploidy and liver growth control. Semin Cancer Biol 2000; 10: 161.
24. Duncan AW, Taylor MH, Hickey RD, et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010; 467: 707.
25. Duncan AW, Hanlon Newell AE, Smith L, et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012; 142: 25.
26. Talisetti A, Hurwitz M, Sarwal M, et al. Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients. Pediatr Transplant 2010; 14: 976.
27. Mazariegos GV, Sindhi R, Thomson AW, Marcos A,. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 2007; 17: 114.
28. Yoshitomi M, Koshiba T, Haga H, et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87: 606.
29. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289.
30. Perner S, Brüderlein S, Hasel C, et al. Quantifying telomere lengths of human individual chromosome arms by centromere-calibrated fluorescence in situ hybridization and digital imaging. Am J Pathol 2003; 163: 1751.
31. Gutierrez-Reyes G, del Carmen Garcia de Leon M, Varela-Fascinetto G, et al. Cellular senescence in livers from children with end stage liver disease. PLoS One 2010; 5: e10231.
32. Venick RS, McDiarmid SV, Farmer DG, et al. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant 2007; 7: 955.
33. Westhoff JH, Schildhorn C, Jacobi C, et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21: 327.
34. Meeker AK, Gage WR, Hicks JL, et al. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am J Pathol 2002; 160: 1259.